Associated Papers
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study.
Jiang H et al.
Translational Lung Cancer Research, 2024
The Mettl3 epitranscriptomic writer amplifies p53 stress responses.
Raj N et al.
Molecular Cell, 2022
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.
Bieging-Rolett KT et al.
Molecular Cell, 2020
Select a paper to view details